SCHEMBL12009801

SCHEMBL12009801

CC[C@H]1OC(C)(C)O[C@H]1[C@@H](C)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12604242 0.83 TSHR (0.32) —
SCHEMBL17682895 0.80 LMNA (0.35) —
SCHEMBL20019588 0.79 — —
SCHEMBL12277432 0.79 — —
SCHEMBL24719300 0.78 LMNA (0.30) —
SCHEMBL14647073 0.76 L3MBTL1 (0.35) —
SCHEMBL11932967 0.74 LMNA (0.37) —
SCHEMBL13644871 0.74 — —
SCHEMBL12009796 0.74 — —
SCHEMBL28208228 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8252909-B2 Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases NEW YORK UNIVERSITY (US) 2012-08-28 — — US disclosed
US-7273852-B2 Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases THE RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) 2007-09-25 — — US disclosed
Send feedback